Press Releases

SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial
January 24, 2024
Displaying 41 - 42 of 42
Print Page
RSS Feeds
Email Alerts
Contact IR